Connect with us

Medical Research

Oral anticoagulant drug retards progression of Alzheimer’s disease in mice

Published

on

A group of researchers has discovered that the use of a particular drug that acts as an oral anticoagulant, dabigatran, can delay the appearance of Alzheimer’s disease in mice. The research was carried out by scientists from the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Rockfeller University of New York while the study was published in the Journal of the American College of Cardiology .

According to the researchers, long-term anticoagulation with dabigatran effectively slowed the progression of Alzheimer’s disease in mice during experiments. Marta Cortés Canteli, a researcher at the CNIC and one of the authors of the study, speaks of an “important progress” regarding effective treatments for Alzheimer’s disease.

To defeat this disease, according to the researcher, there will be a need for personalized therapies aimed at various and different processes that can contribute to the progression of the disease. Among the objectives there is, according to the researcher, cerebral circulation and precisely to treat the latter an oral anticoagulant such as dabigatran can have an effective approach for those Alzheimer’s patients who have a tendency to coagulation.

According to the researcher, in addition to other studies that will have to certify the beneficial action of this drug, there will also be a need to create new diagnostic tools to identify Alzheimer’s patients with a tendency to coagulation with greater precision and efficiency, and precisely this “will be an important research line in the coming years.”

Johnathan Flint

Johnathan is a recent graduate of the Missouri University of Science and Technology with a Bachelor of Medicine, and is an avid reader of numerous medical journals. He recently joined Health Shiner as an editor, researcher and content contributor, and brings a great deal of knowledge and wisdom to our reporting.

2462 White Oak Drive, Weston Missouri, 64098
Ph: 816-640-5682
Email: [email protected]
Johnathan Flint
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Medical Research

Tobacco also linked to worse mental health according to a new study

Published

on

Often, when reference is made to the damage of cigarette smoking, mental health is hardly ever thought about, and yet cigarettes are also bad for you. This is suggested by a study by Professor Hagai Levine of the Hebrew University of Jerusalem published in PLOS ONE.

Levine and colleagues carried out a survey of 2000 Serbian university students from different social and economic backgrounds. The researchers found that students who smoked showed higher rates of clinical depression than their non-smoking peers, two to three times.

Taking into consideration only the students of the University of Pristina, the researchers found that 14% of the smoking students suffered from depression compared to 4% of the non-smoking peers, while for the University of Belgrade the percentages were 19% compared to 11% respectively.

The same students who smoked also showed lower mental health scores than non-smokers. According to Levine, this study adds further evidence that smoking and depression may be linked; although there is no direct evidence yet that smoking causes depression, it can be said that tobacco seems to have a non-positive effect on mental health.

Johnathan Flint

Johnathan is a recent graduate of the Missouri University of Science and Technology with a Bachelor of Medicine, and is an avid reader of numerous medical journals. He recently joined Health Shiner as an editor, researcher and content contributor, and brings a great deal of knowledge and wisdom to our reporting.

2462 White Oak Drive, Weston Missouri, 64098
Ph: 816-640-5682
Email: [email protected]
Johnathan Flint
Continue Reading

Medical Research

One can evaluate hearing quality by analyzing pupil dilation according to researchers

Published

on

It may prove to be a new and effective hearing test developed by a team of neuroscientists at the University of Oregon. According to a statement on the university’s website, it is possible to assess a person’s hearing level by measuring pupil dilation.

According to the same statement, this approach could be useful to understand the quality of hearing in infants, young adults with disabilities and adults with stroke or other diseases and in general in those people for whom direct responses are not possible. The researchers performed experiments on 31 adults by monitoring the size of their pupils with eye detection technology. The detection took place while the same people performed a hearing test and while staring at an object at a monitor.

The study, published in the Journal of the Association for Research in Otorhinolaryngology, explains that this system is inspired by a discovery made by the main author of the study, Avinash Singh Bala, 10 years ago when he noticed changes in the pupils of barn owls in response to unexpected noises in their natural environment.

“What we discovered was that pupil dilation was as sensitive as the button-press method,” Bala explains. “We had presented the first data analyses at the conferences and there was a lot of resistance to the idea that by using an involuntary response we could get results as good as the button-pressing data.”

Johnathan Flint

Johnathan is a recent graduate of the Missouri University of Science and Technology with a Bachelor of Medicine, and is an avid reader of numerous medical journals. He recently joined Health Shiner as an editor, researcher and content contributor, and brings a great deal of knowledge and wisdom to our reporting.

2462 White Oak Drive, Weston Missouri, 64098
Ph: 816-640-5682
Email: [email protected]
Johnathan Flint
Continue Reading

Medical Research

New peanut butter with probiotics developed by scientist

Published

on

A new peanut butter that allows you to acquire probiotic positives was developed by researcher Dan Perlman. Probiotics are microorganisms that live in the digestive system that help to promote digestion, produce important hormones and vitamins and generally strengthen the immune system.

For years, Perlman has been looking for new ways to “pack” probiotics into food to allow people to acquire them without using pills or third-party capsules. Probiotics need to be ingested alive to take advantage of their positive characteristics but if there is not enough water or other energy sources in the food to support these bacteria, they die quickly and are therefore useless once ingested.

Walnut butters seem to be unsuitable for cramming live probiotics as they contain very little water. However, the researcher noted that when freeze-dried peanut butter bacteria come in, the bacteria themselves remain “suspended” in a sort of deep sleep, still alive but ready to get back to work and “wake up” once they are ingested by people.

This is because they remain trapped in the structure of the fat matrix of these foods, a rather crystalline fat.

In the new peanut butter developed by the researcher, there are 500 million to one billion bacteria in a two-spoon portion, the amount of a probiotic pill.

Now the researcher himself is looking for a way to make this new peanut butter with probiotics for commercial use.

Johnathan Flint

Johnathan is a recent graduate of the Missouri University of Science and Technology with a Bachelor of Medicine, and is an avid reader of numerous medical journals. He recently joined Health Shiner as an editor, researcher and content contributor, and brings a great deal of knowledge and wisdom to our reporting.

2462 White Oak Drive, Weston Missouri, 64098
Ph: 816-640-5682
Email: [email protected]
Johnathan Flint
Continue Reading
September 2019
M T W T F S S
    Oct »
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Partners

Trending

Copyright © 2020 Health Shiner | Theme built with assistance from My Silicone Rings